VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ESH AL 2018 | Important stratifications for the treatment of ALL

Speaking from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, Hungary, Torsten Haferlach, MD, of MLL Munich Leukemia Laboratory, Munich, Germany, states his opinions as to which stratifications are the most important to inform treatment decisions in the early treatment of acute lymphoblastic leukemia (ALL).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter